United States Blood Screening Market 2025 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

The Global Blood Screening Market is expected to reach at a high CAGR during the forecast period 2023-2030.

Key Development:

United States: Recent Industry Developments

✅ In August 2025, Exact Sciences Corporation secured an exclusive U.S. license to Freenome's blood-based colorectal cancer screening tests, strengthening its diagnostic portfolio with next-generation non-invasive blood assays. The collaboration advances early cancer detection through advanced liquid biopsy technology.

✅ In January 2025, IntelliGenome received U.S. FDA Breakthrough Device Designation for its CRISPR-based blood test designed to detect Mycobacterium tuberculosis cell-free DNA. The innovation marks progress in next-generation blood screening tools for infectious disease diagnostics.

Japan: Recent Industry Developments

✅ In July 2025, Mirxes Japan, in collaboration with Nagawa Pharmaceutical, launched a nationwide initiative using the microRNA-based blood test GASTROClearTM for early detection of gastric cancer. The project aims to strengthen Japan's preventive healthcare and blood-screening infrastructure.

✅ In March 2025, Otsuka Pharmaceutical Co., Ltd. launched HemeSight®, Japan's first comprehensive genomic profiling assay for hematological malignancies using blood samples. The test has received national health insurance coverage, supporting wider adoption of precision diagnostics.

✅ In February 2025, a Japanese research consortium developed a new proteomic method for ultra-early diagnosis of hereditary diseases using dried filter-paper blood samples. The breakthrough expands the potential for newborn and population-level blood screening.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/blood-screening-market?sb

Recent Mergers and acquisitions:

United States: Recent M&A Developments

✅ In April 2025, SCREEN Holdings Co., Ltd. acquired a majority stake in Kyo Diagnostics K.K., expanding its blood-based cancer diagnostics and screening technology in the U.S. and Japan. The deal boosts innovation in molecular and immunoassay screening.

✅ In March 2025, AccuStem Sciences acquired a proprietary microRNA Signature Classifier for lung cancer risk assessment. This acquisition enhances AccuStem's blood-based cancer screening capabilities, expanding its precision oncology diagnostics offerings.

✅ In February 2025, Hims & Hers Health acquired Trybe Labs, a lab-testing facility, to introduce at-home blood screening services for hormones, cardiac risk, liver function, thyroid function, and prostate health. The acquisition strengthens the company's personalized healthcare and diagnostics portfolio.

Japan: Recent M&A Developments

✅ In October 2025, Sysmex Corporation announced a strategic partnership with QIAGEN N.V. Japan for exclusive distribution of molecular diagnostic products used in blood-based infectious disease and oncology screening. The collaboration expands Sysmex's reach in advanced blood-screening diagnostics.

✅ In September 2025, Sysmex Corporation entered into a share-transfer agreement to acquire the clinical chemistry testing business of JEOL Ltd. The move enhances Sysmex's ability to supply advanced instruments and reagents for blood-based diagnostic screening.

✅ In February 2025, Tokuyama Corporation completed the acquisition of the in-vitro diagnostics and diagnostic-materials business of JSR-01 Corporation. This acquisition strengthens Tokuyama's position in the Japanese blood test and reagent manufacturing market.

Key Players:

=> Bio-Rad Laboratories, Inc., Grifols S.A, Abbott Laboratories, F. Hoffmann-La Roche, Siemens Healthineers, Biomérieux, Thermo Fisher Scientific, Inc., Ortho Clinical Diagnostics, Inc., Becton, Dickinson, and Company, Beckman Coulter (Danaher Corporation). among others.

Growth Forecast Projected:

The Global Blood Screening Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Blood Screening Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=blood-screening-market

Key Segments:

➥ By Product Type: Instruments (Outright Purchase, Rental Purchase), Reagents & Kits (NAT Reagents & Kits, ELISA Reagents & Kits, Other Reagents), Software and Services

➥ By Technology: Next-Generation Sequencing, Nucleic Acid Test, Enzyme-Linked Immunosorbent Assay (ELISA, By Platform, ELISA, By Generation), Western Blot Assay, Rapid Tests, Others

➥ By End-Users: Hospitals, Blood Banks, Others

Regional Analysis for Blood Screening Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Blood Screening producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Blood Screening revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/blood-screening-market?sb

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.